TEK and Crohn disease: The function of soluble Tie-2 in the cancer setting remains unknown; however, soluble levels of Tie-2 were upregulated in patients with Crohn’s disease and ulcerative colitis compared with healthy controls and correlated with more advanced stage disease [40].